The skin graft market was valued at US$ 985.4 million in 2020 and is projected to reach US$ 1,673.5 million by 2028; it is expected to grow at a CAGR of 7.0% from 2021 to 2028.
Skin grafting is a surgery involving the transplantation of skin using various types of skin graft. Skin grafts are also used to treat extensive wounding or trauma and burns. In Skin skin grafting procedure, isa small patch of the skin, which is is removed from a patient’s body part and attached to or transplanted to the affected area of the bodyremoved from skin of the other part of the patient’s body by a surgery. The patch of skin is transplanted or attached to the injured sit or the burnt site.
According to our new research study on “Skin Graft Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Graft Thickness, Applications, Equipment, and End Users. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. Factors such as the increasing numbers of burn injuries and rising prevalence of skin cancer and diabetes fuel the growth of the market. However, the high cost of skin grafting procedures and alternatives hinders the market growth.
Get Sample PDF Copy of Skin Graft Market at: https://www.theinsightpartners.com/sample/TIPHE100001099/
The skin graft market is segmented on the basis of product, graft thickness, application, equipment, end-users, and region. The market, based on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the skin graft market emphasizing on various parameters, such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes the impact of the COVID–19 pandemic on the market across all the regions.
Due to the outbreak of COVID-19 outbreak, various hospitals were are engaged in treating the affected infected people. AdditionallyAs, various wound care centers are located inoperate from hospitals. , Hence, majority of the patients did notare unable to receive the wound care treatment. ~ Approximately 1 in 4 patients is able to receives wound care treatment, and it is expected that there are nearly 6.7 million people across the US those are waiting for the wound treatment. Researchers evaluated the stability of SARS-CoV-2 and influenza A virus (IAV), mixed with culture medium or upper respiratory mucus, on human skin surfaces, and the dermal disinfection effectiveness of 80 per cent (w/w) ethanol against SARS-CoV-2 and IAV. To avoid infecting healthy volunteers, researchers conducted lab experiments using cadaver skin that would have otherwise been used for skin grafts. The outbreak of COVID-19 outbreak has negatively impacted the skin graft market profoundly by affecting the quality care.
Rising Prevalence of Skin Cancer and Diabetes
Skin grafts are ideally preferred post-surgery for skin cancers. Skin grafts are generally referred for local postoperative radiotherapy (PORT) to ensure closure of surgical bed created during radiotherapy. According to Cancer Research UK, ~15,400 new melanoma skin cancer cases are registered in the UK every year, accounting for 42 new cases every day. Incidence rates for melanoma skin cancer are projected to rise by 7% in the UK between 2014 and 2035, to 32 cases per 100,000 people by 2035. Likewise, according to the recent statistics published by the International Agency for Research on Cancer, in 2020, 19.3 million new cancer cases were registered, excluding 18.1 million for nonmelanoma skin cancer. Thus, an increase in the prevalence of skin cancer is likely to contribute to skin grafting in the coming future.
Diabetes is among the most common health conditions prevalent across the globe. According to the International Diabetes Federation’s (IDF) IDF Diabetes Atlas Ninth edition 2019, ~463 million adults were living with diabetes worldwide. The prevalence is estimated to be 700 million by 2045—nearly 79% of adults living with diabetes in low-and-middle incomes countries worldwide. Among the prevalence of diabetes, the proportion of type 2 diabetes is increasing at a much faster rate. According to the IDF, 374 million are at risk of developing type 2 diabetes in the coming future. Among diabetic patients, wound healing is prolonged, which increases the risk of skin infections if it is not healed within a particular time. ~25% of diabetic patients are likely to develop foot ulcers once in their lifetime that often need advanced diabetic wound care. Therefore, there is an increase in demand for skin grafts to treat or cover diabetic foot ulcers by eliminating the chances of contracting skin infections. Thus, the high prevalence rate of skin cancer and diabetes is expected to drive skin graft market in the near future.
Download the Latest COVID-19 Analysis on Skin Graft Market Growth Research Report at: https://www.theinsightpartners.com/covid-analysis-sample/TIPHE100001099/
Product -Based Insights
Based on type, the skin graft market is segmented segmented into autologous, allogeneic, xenogeneic, prosthetic, and isogeneic. The autologous segment accounted forheld the global pharmaceutical intermediate market’sthe largestst market share in 2020, and the market for the same segment market is anticipated to grow faster at the highest rate during 2021–2028. The market growth for autologous segment can be attributed to the wide use of autologous grafts are used widely for treating open burns and wounds.
Application-Based Insights
Based on application, the skin graft market is segmented into burns, extensive wound, skin cancer, and other applications. The burns segment held the largest share of the market in 2020. and The same segment is estimated to register the highest CAGR in the market during the forecast period.
Inorganic strategies such as partnerships, and mergers and acquisitions are commonly adopted by companies to cater tomeet changing customer demand and maintain their brand name across the world. Market players operating in the skin graft market also adopt organic strategies such as product launch and expansion to outstretch their footprint and product portfolio worldwide as well as to meet the growing demand.
B. Braun Melsungen AG, Integra Life Sciences Corporation, Smith & Nephew, AVITA Medical, MiMedx, Organogenesis Inc, Tissue Regenix Group, Zimmer Biomet, De Soutter Medical, and Nouvag AG are among the leading companies operating in the skin graft market. The companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio to meet the rising demands for the skin graft. For instance, in September 2020, MiMedx Group, Inc. launched EpiCord Expandable, a latest advancement in its products portfolio. At the core of this technology is EpiCord, which has demonstrated clinical efficacy in the treatment of diabetic foot ulcers.
Order a Copy of Skin Graft Market Shares, Strategies and Forecasts 2021-2028 Research Report at: https://www.theinsightpartners.com/buy/TIPHE100001099/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/skin-graft-market
